ECPR-China: Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China

Sponsor
Peking Union Medical College Hospital (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT04956497
Collaborator
(none)
300
1
28
10.7

Study Details

Study Description

Brief Summary

The data of patients undergo extracorporeal cardiopulmonary resuscitation (eCPR) will be collected and analyzed. This study will provide useful information about the indication, the start time and others to improve the outcome of ECPR.

Condition or Disease Intervention/Treatment Phase
  • Device: extracorporeal membrane oxygenation (ECMO)

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
300 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Registry Study of Extracorporeal Cardiopulmonary Resuscitation (eCPR) in China
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Oct 31, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Outcome Measures

Primary Outcome Measures

  1. mortality rate [28 days]

    the death rate of the patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age >=18y

  • Cardiac arrested patients accept ECPR treatment

Exclusion Criteria:
  • No

Contacts and Locations

Locations

Site City State Country Postal Code
1 Peking Union Medical College Hospital Beijing China 100730

Sponsors and Collaborators

  • Peking Union Medical College Hospital

Investigators

  • Study Chair: Jun Xu, MD, Peking Union Medical College Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Peking Union Medical College Hospital
ClinicalTrials.gov Identifier:
NCT04956497
Other Study ID Numbers:
  • PUMCH-001
First Posted:
Jul 9, 2021
Last Update Posted:
Jul 9, 2021
Last Verified:
May 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 9, 2021